Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Sunburn 1 Stress, Psychological 1 Stress Disorders, Post-Traumatic 1 Smoking Cessation 1 Sarcoma 1 Prostatic Hyperplasia 1 Motor Activity 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Digestive System Abnormalities 1 Depression 1 Central Nervous System Neoplasms 1 Anxiety Disorders 1 Alzheimer Disease 1 Acquired Immunodeficiency Syndrome 1

Interventions

Tobacco Use Cessation Devices 7 Counseling 6 Varenicline 4 Nicotine Replacement Therapy 3 Early Intervention, Educational 3 Community Health Workers 3 Bupropion 3 Surveys and Questionnaires 2 Nicotine 2 Aspirin 2 zileuton 1 phenethyl isothiocyanate 1 phenanthrene tetraol 1 phenanthrene 1 Zinc Oxide 1 X-Rays 1 Sulindac 1 Spectroscopy, Fourier Transform Infrared 1 Spectrometry, Fluorescence 1 Risk Factors 1 Radiotherapy 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Optical Imaging 1 Nicotine Chewing Gum 1 Molecular Diagnostic Techniques 1 Methods 1 Memantine 1 Immunohistochemistry 1 Gene Expression Profiling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Tobacco Use Disorder × Amyloid × Clear all

NCT06883097 2025-12-17

QMH

Wake Forest University Health Sciences

Phase NA Recruiting

Acquired Immunodeficiency Syndrome, Tobacco Use Disorder, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡